There are over a dozen recognized anemia types, but seven account for the vast majority of cases you’ll encounter clinically or experience as a patient. The fastest way to distinguish them is by mean corpuscular volume (MCV) — the average size of your red blood cells — combined with a handful of targeted lab tests. Below, I’ve broken every major type into a single reference chart, then walked through each one so you actually understand what’s happening in your blood.
Anemia affects roughly 1.8 billion people worldwide, according to the WHO — nearly a quarter of the global population. Yet “anemia” isn’t a single disease. It’s an umbrella term for any condition where your red blood cell count or hemoglobin level drops below normal (generally <13 g/dL in men, <12 g/dL in non-pregnant women). The type dictates everything: cause, treatment, prognosis, and urgency. Get the type wrong, and you treat the wrong problem.
Anemia Types Chart: Side-by-Side Comparison
| Anemia Type | MCV Category | MCV Range (fL) | Primary Cause | Key Diagnostic Lab | First-Line Treatment |
|---|---|---|---|---|---|
| Iron-Deficiency Anemia | Microcytic | <80 | Low iron intake, blood loss, malabsorption | Ferritin <30 ng/mL, low serum iron, high TIBC | Oral/IV iron supplementation |
| Thalassemia | Microcytic | <80 | Genetic mutation in globin chains | Hemoglobin electrophoresis, elevated RBC count with low MCV | Transfusions, folic acid; curative: stem cell transplant |
| Vitamin B12 Deficiency Anemia | Macrocytic | >100 | Poor absorption (pernicious anemia), dietary lack | Serum B12 <200 pg/mL, elevated methylmalonic acid | B12 injections or high-dose oral B12 |
| Folate Deficiency Anemia | Macrocytic | >100 | Dietary deficiency, alcoholism, pregnancy | Serum folate <3 ng/mL, normal methylmalonic acid | Folic acid 1–5 mg/day |
| Anemia of Chronic Disease | Normocytic (can be microcytic) | 80–100 | Chronic inflammation (CKD, RA, cancer) | Low serum iron, low TIBC, ferritin normal/high | Treat underlying disease; EPO agents if CKD |
| Sickle Cell Anemia | Normocytic | 80–100 | HbS gene mutation (autosomal recessive) | Hemoglobin electrophoresis showing HbS | Hydroxyurea, transfusions, voxelotor; curative: gene therapy |
| Aplastic Anemia | Normocytic to macrocytic | 80–110 | Bone marrow failure (autoimmune, drugs, idiopathic) | Pancytopenia on CBC, hypocellular bone marrow biopsy | Immunosuppressive therapy; stem cell transplant if severe |
Microcytic Anemias (MCV <80 fL)
Iron-Deficiency Anemia
This is the single most common anemia type globally, responsible for roughly 50% of all anemia cases. Red blood cells come out small and pale (microcytic, hypochromic) because there isn’t enough iron to build hemoglobin properly.
The classic lab picture: ferritin below 30 ng/mL, low serum iron, elevated total iron-binding capacity (TIBC), and low transferrin saturation. In menstruating women, heavy periods are the #1 cause. In postmenopausal women and men, the first move is ruling out GI blood loss — occult colon cancer, ulcers, celiac disease.
Treatment is straightforward: oral ferrous sulfate 325 mg (65 mg elemental iron) taken every other day on an empty stomach with vitamin C. If oral iron fails or can’t be tolerated, IV iron infusions (ferric carboxymaltose, iron sucrose) bypass the gut entirely.
Thalassemia
Thalassemia is the other major microcytic anemia — and the one most often confused with iron deficiency on initial labs. The giveaway? In thalassemia trait, the RBC count is often elevated (>5 million/µL) while MCV is disproportionately low. The Mentzer index (MCV ÷ RBC count) below 13 points toward thalassemia; above 13 suggests iron deficiency.
Alpha and beta thalassemia are caused by mutations that reduce production of their respective globin chains. Thalassemia trait (minor) usually needs no treatment. Thalassemia major (Cooley’s anemia) requires regular transfusions starting in infancy and iron chelation therapy to prevent organ damage from iron overload.
Macrocytic Anemias (MCV >100 fL)
Vitamin B12 Deficiency (Including Pernicious Anemia)
When B12 drops below ~200 pg/mL, DNA synthesis in developing red blood cells stalls. The cells keep growing without dividing, producing abnormally large RBCs called megaloblasts. A peripheral blood smear often shows hypersegmented neutrophils — a classic finding that points straight to megaloblastic anemia.
What makes B12 deficiency uniquely dangerous is its neurological fallout. Subacute combined degeneration of the spinal cord causes numbness, tingling, balance problems, and cognitive changes that can become permanent if left untreated. Pernicious anemia — an autoimmune destruction of gastric parietal cells — is the most well-known cause, but gastric bypass surgery, Crohn’s disease, and strict vegan diets without supplementation also qualify.
Folate Deficiency Anemia
Folate deficiency looks nearly identical to B12 deficiency on a CBC — big red cells, megaloblastic changes — but without the neurological symptoms. The key distinguishing lab: methylmalonic acid is elevated in B12 deficiency but normal in folate deficiency.
Common culprits include poor diet, alcoholism (folate is the first nutrient to drop in heavy drinkers), and increased demand during pregnancy. Treatment is simple: oral folic acid 1 mg daily. But always check B12 levels first — supplementing folate alone can mask a B12 deficiency and allow irreversible nerve damage to progress silently.
Normocytic Anemias (MCV 80–100 fL)
Anemia of Chronic Disease
Anemia of chronic disease (ACD) is the second most common anemia type worldwide and the most common in hospitalized patients. Chronic inflammation from conditions like rheumatoid arthritis, cancer, chronic kidney disease, or HIV triggers hepcidin release from the liver. Hepcidin traps iron inside cells, starving the bone marrow even when total body iron stores are adequate.
The lab hallmark: ferritin is normal or elevated (often >100 ng/mL) while serum iron and TIBC are both low. This distinguishes it from iron-deficiency anemia, where ferritin is low and TIBC is high. The most effective treatment is addressing the underlying disease. In CKD-associated anemia, erythropoiesis-stimulating agents (ESAs) like epoetin alfa become essential when hemoglobin drops below 10 g/dL.
Sickle Cell Anemia
A single point mutation in the beta-globin gene (glutamic acid → valine at position 6) produces hemoglobin S, which polymerizes under low-oxygen conditions and deforms red blood cells into rigid sickle shapes. These cells clog small vessels, causing excruciating vaso-occlusive crises, organ damage, and a chronic hemolytic anemia with hemoglobin often hovering around 6–9 g/dL.
Hydroxyurea remains the backbone of disease-modifying therapy — it boosts fetal hemoglobin (HbF) production, which prevents sickling. In 2023, the FDA approved two gene therapies (Casgevy and Lyfgenia), marking the first CRISPR-based treatments for any disease and offering a potential functional cure.
Aplastic Anemia
Aplastic anemia is rare (~2 cases per million per year in Western countries) but serious. The bone marrow fails to produce adequate blood cells, causing pancytopenia — low red cells, white cells, and platelets simultaneously. Most cases are autoimmune (T-cells attacking stem cells), but drugs like chloramphenicol, benzene exposure, and certain viral infections can trigger it.
Severe aplastic anemia (defined as absolute neutrophil count <500/µL, platelet count <20,000/µL, and reticulocyte count <1%) carries high mortality without treatment. For patients under 40 with a matched sibling donor, allogeneic stem cell transplant is the preferred approach. Otherwise, combination immunosuppression with antithymocyte globulin (ATG) plus cyclosporine achieves response rates around 60–70%.
When to See a Doctor
- Hemoglobin below 10 g/dL — warrants prompt evaluation regardless of symptoms
- Unexplained fatigue lasting more than 2–3 weeks, especially with pallor or shortness of breath on exertion
- Neurological symptoms (tingling, numbness, balance issues) — may indicate B12 deficiency requiring urgent treatment
- Dark or bloody stools — could signal GI blood loss driving iron-deficiency anemia
- Family history of sickle cell or thalassemia — get hemoglobin electrophoresis if you haven’t been screened
- Known chronic disease with worsening fatigue — ask your doctor to recheck your CBC and iron panel
When requesting bloodwork, ask specifically for a CBC with differential, reticulocyte count, ferritin, serum iron, TIBC, B12, and folate. This panel covers the majority of common anemia types in a single draw.
Frequently Asked Questions
What is the most common type of anemia?
Iron-deficiency anemia, by a wide margin. It accounts for roughly half of all anemia cases globally and affects an estimated 1.2 billion people. Women of reproductive age and young children in low-income countries are hit hardest.
Can you have more than one type of anemia at the same time?
Yes, and it’s more common than people realize. A classic example: a patient with rheumatoid arthritis (anemia of chronic disease) who also develops iron-deficiency anemia from NSAID-related GI bleeding. When two types overlap, the MCV can appear deceptively normal because microcytic and macrocytic processes cancel each other out. The reticulocyte count and a comprehensive iron panel help untangle things.
How do I tell the difference between iron-deficiency anemia and thalassemia?
Both are microcytic, but look at the RBC count and the RDW (red cell distribution width). Iron deficiency typically shows a low RBC count with a high RDW (lots of variation in cell size). Thalassemia trait often shows an elevated RBC count with a normal or mildly elevated RDW. Hemoglobin electrophoresis confirms thalassemia; ferritin below 30 ng/mL confirms iron deficiency.
Does mild anemia need treatment?
It depends on the cause. Mild iron-deficiency anemia (hemoglobin 10–12 g/dL) often resolves with dietary changes and supplementation. But mild anemia can also be the first sign of colon cancer, celiac disease, or myelodysplastic syndrome. The hemoglobin number alone doesn’t tell you whether it’s benign — the why matters more than the how much.
Is anemia of chronic disease the same as iron-deficiency anemia?
No, and confusing them leads to inappropriate treatment. In anemia of chronic disease, iron is trapped and unavailable — giving more iron won’t help and can actually cause harm (iron overload). The distinguishing lab: ferritin is normal or high in chronic disease anemia versus low in true iron deficiency. If ferritin falls in an ambiguous range (30–100 ng/mL), soluble transferrin receptor levels can help differentiate.
